Prenatal and new-born genetic testing Market Size, Share, Growth Report 2032

Prenatal and new-born genetic testing Market Insights

According to Zion Market Research, the global Prenatal and new-born genetic testing Market was worth USD 7.58 Billion in 2023. The market is forecast to reach USD 26.87 Billion by 2032, growing at a compound annual growth rate (CAGR) of 15.1% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Prenatal and new-born genetic testing Market industry over the next decade.

Request Free Sample

Prenatal and new-born genetic testing Market: Industry Perspective

The global Prenatal and new-born genetic testing market size was worth around USD 4.7 Billion in 2020 and is predicted to grow to around USD 10.11 Billion by 2028 with a compound annual growth rate (CAGR) of roughly 11.8% between 2021 to 2028. The report offers an assessment and analysis of the Prenatal and newborn genetic testing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Prenatal and New-born Genetic Testing Market: Overview

Prenatal testing is referred to as medical tests performed during pregnancy to determine genetic disorders as well as birth defects in the fetus. Generally, these tests are carried out for detecting Tay-Sachs disease, sickle cell anemia, cystic fibrosis, and Down’s syndrome. Screening is continued post-baby birth and this testing is named newborn genetic testing. It is performed for determining genetically inherited disorders and phenylketonuria, critical congenital heart ailment, hearing loss, and muscular spinal atrophy. Prenatal and newborn genetic screening helps in reducing infant mortalities and enhances patient health by enabling effective diagnosis & treatment.

Prenatal and New-born Genetic Testing Market: Growth Drivers

Technological breakthroughs in healthcare & growing awareness about the advantages of prenatal & newborn genetic testing activities will steer prenatal and newborn genetic testing market growth. The surge in chromosomal disorders and the occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up the expansion of the prenatal and newborn genetic testing industry size during the forecast timeline. The growing occurrence of genetic disorders in infants has translated into the need for prenatal and newborn genetic testing activities, thereby driving prenatal and newborn genetic testing market trends. However, ethical issues pertaining to prenatal & newborn genetic testing and cultural barriers can impede the growth of the prenatal and newborn genetic testing industry growth over the years ahead.

Prenatal and new-born genetic testing Market: Report Scope

Prenatal and new-born genetic testing Market: Regional Landscape

North America To Maintain Market Dominance During Forecast Timespan

The regional market dominance of North America over 2024-2032 can be due to supportive government healthcare policies along with the easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, the rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for the prenatal and newborn genetic testing market in North America over the forecast period. The surge in pregnancies in women after 35 years has posed a risk of a child being born with anomalies and this has prompted the need for prenatal and newborn genetic testing activities, thereby promulgating growth in the size of the prenatal and newborn genetic testing market in the North American sub-continent.

Prenatal and new-born genetic testing Market: Competitive Landscape

Key participants profiled in the report and influencing market growth are

• Natera
• Ariosa Diagnostics (Roche)
• Trivitron Healthcare
• Sequenom
• Berry Genomics
• Qiagen
• BGI
• Biorad
• Illumina
• Laboratory Corporation of America
• Verinata Health

The global Prenatal and new-born genetic testing Market is segmented as follows:

By Technology

• Screening
• Diagnostic

By End-Use

• Hospitals
• Maternity & Specialty Clinics
• Diagnostic Units

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa